863 related articles for article (PubMed ID: 31451835)
1. Radiotherapy after skin-sparing mastectomy with immediate breast reconstruction in intermediate-risk breast cancer : Indication and technical considerations.
Hehr T; Baumann R; Budach W; Duma MN; Dunst J; Feyer P; Fietkau R; Haase W; Harms W; Krug D; Piroth MD; Sedlmayer F; Souchon R; Wenz F; Sauer R;
Strahlenther Onkol; 2019 Nov; 195(11):949-963. PubMed ID: 31451835
[TBL] [Abstract][Full Text] [Related]
2. A positive margin is not always an indication for radiotherapy after mastectomy in early breast cancer.
Truong PT; Olivotto IA; Speers CH; Wai ES; Berthelet E; Kader HA
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):797-804. PubMed ID: 14967436
[TBL] [Abstract][Full Text] [Related]
3. The role of different lymph node staging systems in predicting prognosis and determining indications for postmastectomy radiotherapy in patients with T1-T2pN1 breast carcinoma.
Kustić D; Klarica Gembić T; Grebić D; Petretić Majnarić S; Nekić J
Strahlenther Onkol; 2020 Nov; 196(11):1044-1054. PubMed ID: 32710122
[TBL] [Abstract][Full Text] [Related]
4. Minimal impact of postmastectomy radiation therapy on locoregional recurrence for breast cancer patients with 1 to 3 positive lymph nodes in the modern treatment era.
Miyashita M; Tada H; Suzuki A; Watanabe G; Hirakawa H; Amari M; Kakugawa Y; Kawai M; Furuta A; Sato K; Yoshida R; Ebata A; Sasano H; Jingu K; Ohuchi N; Ishida T
Surg Oncol; 2017 Jun; 26(2):163-170. PubMed ID: 28577722
[TBL] [Abstract][Full Text] [Related]
5. Favorable Outcome with Close Margins in Patients Undergoing Nipple/Skin Sparing Mastectomy with Immediate Breast Reconstruction: 5-year Follow-up.
Özkurt E; Tükenmez M; Güven E; Çelet Özden B; Öner G; Müslümanoğlu M; İğci A; Özmen V; Küçücük S; Cabioğlu N
Balkan Med J; 2018 Jan; 35(1):84-92. PubMed ID: 28958980
[TBL] [Abstract][Full Text] [Related]
6. Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy.
Truong PT; Olivotto IA; Whelan TJ; Levine M;
CMAJ; 2004 Apr; 170(8):1263-73. PubMed ID: 15078851
[TBL] [Abstract][Full Text] [Related]
7. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
[TBL] [Abstract][Full Text] [Related]
8. Post-mastectomy radiotherapy for women with early breast cancer and one to three positive lymph nodes.
Verma R; Chandarana M; Barrett J; Anandadas C; Sundara Rajan S
Cochrane Database Syst Rev; 2023 Jun; 6(6):CD014463. PubMed ID: 37327075
[TBL] [Abstract][Full Text] [Related]
9. Are there patients with T1 to T2, lymph node-negative breast cancer who are "high-risk" for locoregional disease recurrence?
Mamtani A; Patil S; Stempel MM; Morrow M
Cancer; 2017 Jul; 123(14):2626-2633. PubMed ID: 28334423
[TBL] [Abstract][Full Text] [Related]
10. Postmastectomy radiotherapy improves disease-free survival of high risk of locoregional recurrence breast cancer patients with T1-2 and 1 to 3 positive nodes.
He ZY; Wu SG; Zhou J; Li FY; Lin Q; Lin HX; Sun JY
PLoS One; 2015; 10(3):e0119105. PubMed ID: 25781605
[TBL] [Abstract][Full Text] [Related]
11. DEGRO practical guidelines for radiotherapy of breast cancer IV: radiotherapy following mastectomy for invasive breast cancer.
Wenz F; Sperk E; Budach W; Dunst J; Feyer P; Fietkau R; Haase W; Harms W; Piroth MD; Sautter-Bihl ML; Sedlmayer F; Souchon R; Fussl C; Sauer R;
Strahlenther Onkol; 2014 Aug; 190(8):705-14. PubMed ID: 24888511
[TBL] [Abstract][Full Text] [Related]
12. Locoregional recurrence risk factors in breast cancer patients with positive axillary lymph nodes and the impact of postmastectomy radiotherapy.
Nagao T; Kinoshita T; Tamura N; Hojo T; Morota M; Kagami Y
Int J Clin Oncol; 2013 Feb; 18(1):54-61. PubMed ID: 22068463
[TBL] [Abstract][Full Text] [Related]
13. Postmastectomy radiotherapy in intermediate risk stage I-II breast cancer patients.
Mladenovic J; Susnjar S; Gavrilovic D; Borojevic N
J BUON; 2007; 12(2):215-20. PubMed ID: 17600875
[TBL] [Abstract][Full Text] [Related]
14. Oncologic outcomes and radiation safety of nipple-sparing mastectomy with intraoperative radiotherapy for breast cancer.
Pan L; Ye C; Chen L; Tang W; Zhang X; Gao J; Wu R; Ye X; Tan W; Wan M; Zheng W
Breast Cancer; 2019 Sep; 26(5):618-627. PubMed ID: 30888580
[TBL] [Abstract][Full Text] [Related]
15. Skin-sparing mastectomy and immediate reconstruction: oncologic risks and aesthetic results in patients with early-stage breast cancer.
Slavin SA; Schnitt SJ; Duda RB; Houlihan MJ; Koufman CN; Morris DJ; Troyan SL; Goldwyn RM
Plast Reconstr Surg; 1998 Jul; 102(1):49-62. PubMed ID: 9655407
[TBL] [Abstract][Full Text] [Related]
16. Postmastectomy radiotherapy: indications and implications.
Walsh SM; Lowery AJ; Prichard RS; McDermott EW; Evoy D; Geraghty J
Surgeon; 2014 Dec; 12(6):310-5. PubMed ID: 25037652
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors for breast cancer patients with T1-2 tumors and 1-3 positive lymph nodes and the role of postmastectomy radiotherapy in these patients.
Zhao JM; An Q; Sun CN; Li YB; Qin ZL; Guo H; Zeng X; Zhang YT; Wei LL; Han N; Sun SC; Zhang N
Breast Cancer; 2021 Mar; 28(2):298-306. PubMed ID: 32940902
[TBL] [Abstract][Full Text] [Related]
18. Incorporating Risk Factors to Identify the Indication of Post-mastectomy Radiotherapy in N1 Breast Cancer Treated with Optimal Systemic Therapy: A Multicenter Analysis in Korea (KROG 14-23).
Park HJ; Shin KH; Kim JH; Ahn SD; Kim JY; Park W; Kim YB; Kim YJ; Kim JH; Kim K; Park KR; Shin HS; Jeong BK; Lee SY; Kim S
Cancer Res Treat; 2017 Jul; 49(3):739-747. PubMed ID: 27764904
[TBL] [Abstract][Full Text] [Related]
19. Chest wall radiotherapy: middle ground for treatment of patients with one to three positive lymph nodes after mastectomy.
Macdonald SM; Abi-Raad RF; Alm El-Din MA; Niemierko A; Kobayashi W; McGrath JJ; Goldberg SI; Powell S; Smith B; Taghian AG
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1297-303. PubMed ID: 19327896
[TBL] [Abstract][Full Text] [Related]
20. Immediate tissue expander or implant-based breast reconstruction does not compromise the oncologic delivery of post-mastectomy radiotherapy (PMRT).
Jethwa KR; Kahila MM; Whitaker TJ; Harmsen WS; Corbin KS; Park SS; Yan ES; Lemaine V; Boughey JC; Mutter RW
Breast Cancer Res Treat; 2017 Jul; 164(1):237-244. PubMed ID: 28417333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
